Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration

被引：0
|
作者：
Nathalie Massamba
Ali Dirani
Nathalie Butel
Christine Fardeau
Bahram Bodaghi
April Ingram
Phuc Lehoang
机构：
[1] Pitié salpetrière Hospital,Department of Ophthalmology
[2] UPMC,Department of Ophthalmology
[3] University of Lausanne,Fondation Asile des Aveugles (Foundation Asylum for the Blind)
[4] Jules Gonin Eye Hospital,Department of Ophthalmology
[5] University Paris VI GH Pitié Salpétrière,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2017年 / 255卷
关键词：
Aflibercept; Outer retinal tubulations; Anti-VEGF; Exudative AMD; SD-OCT; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：61 / 67
页数：6
相关论文
共 50 条
  • [1] Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration
    Massamba, Nathalie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [2] Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration
    Massamba, Nathalie
    Dirani, Ali
    Butel, Nathalie
    Fardeau, Christine
    Bodaghi, Bahram
    Ingram, April
    Lehoang, Phuc
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (01) : 61 - 67
  • [3] INTRAVITREAL AFLIBERCEPT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION RESISTANT TO INTRAVITREAL RANIBIZUMAB
    Narayan, Daniel
    Muecke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 119 - 119
  • [4] Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab
    Narayan, Daniel Sanju
    Muecke, James
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2015, 63 (11) : 832 - 836
  • [5] Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
    Barthelmes, Daniel
    Campain, Anna
    Phuc Nguyen
    Arnold, Jennifer J.
    McAllister, Ian L.
    Simpson, Judy M.
    Hunyor, Alex P.
    Guymer, Robyn
    Essex, Rohan W.
    Morlet, Nigel
    Gillies, Mark C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (12) : 1640 - 1645
  • [6] Intravitreal Bevacizumab and Aflibercept for the Treatment of Exudative Age-Related Macular Degeneration
    Selid, Paul D.
    Jundt, Michael C.
    Fortney, Aaron C.
    Beal, James R.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2014, 45 (04): : 275 - 281
  • [7] Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
    Karaca, Umut
    Durukan, Ali Hakan
    Erdurman, Fazil Cuneyt
    Sobaci, Gungor
    Bayraktar, Mehmet Zeki
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2012, 42 (01): : 25 - 29
  • [8] Efficacy of intravitreal aflibercept in exudative age-related macular degeneration (AMD) refractory to intravitreal ranibizumab and bevacizumab
    Lau, Stephen
    Acharya, Nachiketa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [9] Results of Re-switch from Intravitreal Aflibercept to Ranibizumab in Patients with Exudative Age-related Macular Degeneration
    Waibel, Soeren
    Matthe, Egbert
    Sandner, Dirk
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (05) : 616 - 621
  • [10] Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability
    Yoko Nomura
    Yasuo Yanagi
    Japanese Journal of Ophthalmology, 2015, 59 : 261 - 265
12345